Kits and methods to distinguish false labor and true labor
US-11204354-B2 · Dec 21, 2021 · US
US12287340B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12287340-B2 |
| Application number | US-202418414339-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 16, 2024 |
| Priority date | Nov 5, 2015 |
| Publication date | Apr 29, 2025 |
| Grant date | Apr 29, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Kits and methods to distinguish between false and true labor are provided. The kits and methods can utilize differences in abundance and/or differences in the rate of change in abundance of B7-H2, SORC2, TF, C1-Esterase Inhibitor, Ran, IMDH1 and/or PGAM1, as markers of true labor.
Opening claim text (preview).
What is claimed is: 1. A kit comprising: an array that measures tissue factor (TF) in combination with Ras-related Nuclear protein (Ran), Inosine-5′-monophosphate dehydrogenase (IMDH1), and Phosphoglycerate mutase 1 (PGAM1), from a sample obtained from a pregnant female. 2. The kit of claim 1 comprising instructions that direct calculation of changes in abundance (CA) of TF, Ran, IMDH1, and PGAM1 as compared to a reference level calculated from samples derived from a reference population, at a time when members of said reference population were not in true labor. 3. The kit of claim 2 comprising instructions that direct calculation of a true labor score using change of abundance of true labor markers, wherein CA TF , CA Ran , CA IMDH1 , and CA PGAM1 are used in a Linear Discriminant Analysis Model. 4. The kit of claim 3 comprising instructions that direct analysis of the true labor score; wherein the true labor score comprises two threshold values, X and Y, wherein a true labor score≤X denotes that the pregnant female is in false labor, and wherein a true labor score>Y denotes that the pregnant female is in true labor. 5. The kit of claim 1 , comprising instructions that direct sample collection be obtained from a pregnant female between 33 and 40 weeks of the female's pregnancy. 6. The kit of claim 1 , comprising instructions to collect a plasma or serum sample. 7. The kit of claim 1 , comprising instructions to collect the sample when the pregnant female is experiencing symptoms associated with false labor and true labor, wherein the symptoms optionally are contractions. 8. The kit of claim 1 , wherein the array comprises one or more well(s) coated with: anti-TF antibodies; and/or anti-Ran antibodies; and/or anti-IMDH1 antibodies; and/or anti-PGAM1 antibodies.
for evaluating statistical data {, e.g. average values, frequency distributions, probability functions, regression analysis (forecasting specially adapted for a specific administrative, business or logistic context G06Q10/04)} · CPC title
Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour · CPC title
Calcium binding proteins, e.g. calmodulin · CPC title
with an insoluble carrier for immobilising immunochemicals · CPC title
Phosphotransferases (phosphomutases) (5.4.2) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.